GENOMIC RISK PANEL
Genomic risk insight for preventive cardiometabolic health
V-Risk is a B2B genomic risk assessment panel designed to add a polygenic risk-based reporting layer to laboratories, clinics and preventive health workflows.
V-Risk Report
Sample
CAD
High
T2D
Moderate
AF
Elevated
Lp(a)
Low
Clinician-supported interpretation →
THE CHALLENGE
The problem
Traditional health assessments are essential, but inherited cardiometabolic risk is often not reported in a structured, responsible and partner-ready format.
01
Risk can be missed
Inherited predisposition may not be visible in routine measurements.
02
PRS is hard to deploy
Many teams lack analytics, reporting and communication infrastructure.
03
Language matters
Genetic risk must be explained without deterministic claims.
THE SOLUTION
The V-Risk solution
V-Risk translates polygenic risk into structured, clinician-supported reports for preventive cardiometabolic health.
Science-based. Report-ready.
Partner-focused.
Genotype Data
Raw genomic input
1
Input
PRS Analytics
Polygenic risk score computation
2
Processing
Structured Report
Professional genomic risk output
3
Output
Professional Review
Clinician-guided interpretation
4
Delivery
WHY V-RISK
Key benefits
Better-informed risk assessment
Adds a genomic layer to clinical, family-history and lifestyle context for a superior health overview.
01
Personalized prevention
Supports health conversations with specific genomic insights.
Clinician-friendly reporting
Structured output tailored for medical professionals.
Partner-ready implementation
Seamlessly integrates into workflows of laboratories, hospitals, and medical distributors.
Science-based analytics
Phenotype-focused PRS interpretation for precise cardiometabolic risk profiles.
Pilot-first deployment
Test the fit of our genomic layer before full-scale commercial commitment.
WHO IT'S FOR
Use cases
PRIMARY TARGET
Genetic laboratories
Add cardiometabolic genomic risk reporting to an existing test portfolio with ease.
→ Learn more
Preventive clinics
Differentiate executive check-up and preventive health programs with a genomic layer.
Private hospitals
Support cardiology, endocrinology and check-up workflows with structured reporting.
Distributors
Introduce a controlled B2B genomic risk product to regional markets and institutional partners.
OUR APPROACH
Why V-Risk / Why Variome
Built at the intersection of PRS analytics, clinical insight, responsible reporting and partner-oriented implementation.
01
Clinical foundation
Informed by cardiometabolic risk research and clinically characterized cohort work.
Science-backed
02
Report quality
Designed for structured, understandable and institution-ready communication.
→ Structured output
03
B2B mindset
Built for partner workflows rather than generic consumer genetic testing.
→ Partner-ready
GET STARTED
Ready to explore how V-Risk
fits your workflow?
Request a focused pilot discussion with Variome to assess use case, data flow, report structure and partnership options.
✓ Science-based analytics
🔒 Data-safe workflows
⚕ Clinician-supported reporting